Business transformation services company Genpact (NYSE: G) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year on year to $1.30 billion. On the other hand, next quarter’s revenue guidance of $1.33 billion was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.98 per share was 6.3% above analysts’ consensus estimates.
Is now the time to buy G? Find out in our full research report (it’s free for active Edge members).
Genpact (G) Q1 CY2026 Highlights:
- Revenue: $1.30 billion vs analyst estimates of $1.29 billion (6.7% year-on-year growth, 0.5% beat)
- Adjusted EPS: $0.98 vs analyst estimates of $0.92 (6.3% beat)
- Adjusted EBITDA: $244.5 million vs analyst estimates of $242.9 million (18.9% margin, 0.7% beat)
- Revenue Guidance for Q2 CY2026 is $1.33 billion at the midpoint, below analyst estimates of $1.34 billion
- Adjusted EPS guidance for Q2 CY2026 is $0.97 at the midpoint
- Operating Margin: 15.3%, in line with the same quarter last year
- Constant Currency Revenue rose 5.6% year on year (8.3% in the same quarter last year)
- Market Capitalization: $5.85 billion
StockStory’s Take
Genpact’s first quarter results reflected growing demand for its advanced technology offerings, with management emphasizing the success of agentic and AI-led solutions as key drivers. CEO Balkrishan Kalra highlighted that “Advanced Technology Solutions revenue growth accelerated to 24% year-over-year,” as a broad client base shifted to more outcome-driven, non-FTE-led operations. The company’s focus on high-value, recurring contracts and notable wins in both new and existing client segments contributed to margin expansion and strong earnings growth, even as core business services revenue grew at a slower pace. Management underscored that the acceleration in advanced technology was supported by a record pipeline and large-deal wins during the quarter.
Looking ahead, Genpact’s guidance is rooted in expectations for continued growth in its agentic and advanced technology solutions, particularly as clients move further toward AI-enabled operations. Management cited a robust pipeline and record backlog as foundations for expected double-digit adjusted EPS growth, with CFO Michael Weiner noting, “Given the accelerating momentum in agentic, our strengthening partnerships, and healthy demand for data and AI, we now expect Advanced Technology Solutions to grow at least 20%.” The company is also prioritizing margin expansion through a shift to higher-value, recurring revenue streams, while continuing to invest in strategic partnerships and proprietary offerings.
Key Insights from Management’s Remarks
Management attributed first quarter momentum to accelerated adoption of agentic operations, a growing mix of recurring revenue, and strong execution in large deal capture, especially within advanced technology segments.
- Agentic solutions momentum: Genpact nearly doubled the total contract value of its agentic solutions compared to all of 2025, reflecting rapid client adoption of autonomous, AI-driven workflow automation. These solutions are increasingly integrated into client operations and are forming a recurring revenue base that is decoupled from headcount, supporting higher margins.
- Strategic partnership expansion: The company deepened its relationship with Google, launching a new alliance to create agentic and AI-led solutions for finance teams. This partnership leverages Genpact’s process intelligence with Google Cloud’s AI infrastructure, as showcased in recent client wins and public demonstrations.
- Core business services stability: While advanced technology led overall growth, core business services—which include traditional digital operations and industry-specific solutions—continued to show steady demand, particularly as clients seek to modernize legacy operations.
- Shift to outcome-based models: Management noted a strategic transition from traditional full-time equivalent (FTE) billing toward fixed-fee, outcome-based, and IP-led commercial models. Non-FTE revenue rose to 48% of the total, supporting more predictable and higher-quality earnings streams.
- Large deal traction: Genpact signed six large deals (each over $50 million in value) in the quarter, contributing to a record backlog and reinforcing its position as a strategic transformation partner for major global enterprises.
Drivers of Future Performance
Genpact’s outlook is anchored by ongoing demand for agentic and AI-enabled solutions, a growing backlog, and a transition to more durable, high-margin recurring revenues.
- Advanced Technology Solutions growth: Management expects Advanced Technology Solutions, which includes data, AI, and agentic offerings, to grow at least 20% in the coming year, driven by both new client wins and expanded adoption among existing clients. The company believes this mix shift will improve both revenue quality and operating margins as agentic solutions scale.
- Margin expansion focus: The shift to outcome-based and IP-led models, along with operational leverage from AI, is expected to drive gross and operating margin expansion. CFO Michael Weiner noted that the resulting business model should deliver “double-digit adjusted EPS growth, again faster than revenue.”
- Execution risks and market trends: Management acknowledged broader industry uncertainties, such as delays in client decision-making seen by peers, but believes Genpact’s context-rich process expertise and expanded partner ecosystem provide insulation. However, execution on large deals and successful scaling of new solutions will be critical for sustaining growth.
Catalysts in Upcoming Quarters
In future quarters, our analysts will closely watch (1) the pace at which clients transition from traditional digital operations to agentic and AI-led models, (2) the execution and ramp-up of large, multi-year deals in the advanced technology segment, and (3) the impact of expanded partnerships—particularly with Google—on solution adoption and recurring revenue mix. Ongoing margin improvement and successful scaling of proprietary offerings will also be key markers of progress.
Genpact currently trades at $34.41, in line with $34.48 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
